本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

13.94
+0.63994.81%
成交量:38.90万
成交额:538.37万
市值:14.66亿
市盈率:-9.63
高:14.10
开:13.47
低:13.41
收:13.30
数据加载中...
2023/06/12

重要事件披露

Form 8-K - Current report
2023/05/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/06

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/09/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

重要事件披露

8-K - Current report